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he study in the Journal byMeijboom et al. (1) and the accompanying
ditorial by Nissen (2) seem disconnected from each other.
The Meijboom et al. (1) study was a diagnostic performance
tudy that aimed to establish the accuracy of the newly introduced
echnology. This was a well-executed prospective multicenter,
ultivendor study, the results of which indicate high diagnostic
ccuracy of computed tomography coronary angiography (CTCA)
n symptomatic patients with a high prevalence of coronary artery
isease (CAD) that is superior to other methods of noninvasive
ardiac testing. Furthermore, despite the high prevalence of
ignificant CAD, the ability of CTCA to exclude obstructive
oronary stenosis in the Meijboom et al. (1) study approached
00%, which is higher than that reported for all other forms of
oninvasive cardiac testing.
In contrast, the accompanying editorial by Nissen (2) briefly
iscusses the Meijboom et al. (1) study but concentrated much of
ts text to describing the history of invasive coronary angiography,
tress testing, CTCA, and the need for patient-centered outcomes
tudies for CTCA.
There are several important observations that are worthy of note:
. The cart should not be placed before the horse. The first step
for assessment of any new diagnostic technology is the estab-
lishment of its diagnostic accuracy, and this purpose was well
served by the Meijboom et al. (1) study. Indeed, the Meijboom
et al. (1) study now joins 2 other prospective multicenter studies
(ACCURACY [Assessment by Coronary Computed Tomo-
graphic Angiography of Individuals Undergoing Invasive Cor-
onary Angiography] and CORE-64 [Coronary Artery Evalua-
tion Using 64-Row Multidetector Computed Tomography
Angiography]) evaluating the accuracy of CTCA (3,4). There
have been no large-scale, prospective, multicenter studies of
diagnostic accuracy performed for the stress imaging tests that
have become the de facto standard of care.
. “When will we get there?” is a fair question. “Why aren’t we
there?” is not. The introduction of CTCA occurred 3 years ago,
just enough time to definitively establish diagnostic accuracy.
Studies regarding CTCA now need to assess its costs to the
health care system and its clinical effectiveness for patients, and
these types of trials have been proposed and designed and are
being implemented.
. “Res ipsa loquitur.” Until these trials can be completed, com-
mon sense should dictate clinical use of noninvasive cardiac
testing. The majority of patients for whom noninvasive cardiac
testing is most appropriate will not have significant CAD. As
such, a test that can successfully exclude CAD with an accuracy
approaching 100% should be employed to identify individuals
in which no further need for testing or therapy is necessary. cWith its very high negative predictive value, an immediate
benefit of the use of this test would be to eliminate the need for
unnecessary invasive coronary angiography.
. Negative is not necessarily bad. Although it is a complex task to
ascribe an economic value to the intangibles of a negative test in a
scientific study, it is nevertheless very straightforward to a patient.
A “negative test” can be worth as much—if not more—than a
“positive test,” because the value of peace of mind to a concerned
symptomatic patient is unambiguous: it is priceless.
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Flawed Comparison
e read with interest the recent paper by Meijboom et al. (1) and
he corresponding editorial by Nissen (2). We wish to make 3
omments.
First, as with almost all previous validation studies comparingomputed tomography coronary angiography (CTCA) with inva-
